Travis E. Grotz, M.D., performs clinical and translational research in sarcoma and peritoneal and gastrointestinal cancers with a focus on clinical trials utilizing regional therapies for advanced malignancies. He also serves as an institutional principal investigator on multidisciplinary clinical trials.
Dr. Grotz's clinical research work focuses on evaluating diagnostic and treatment strategies to improve perioperative outcomes for patients undergoing sarcoma, peritoneal and gastrointestinal surgeries. Specifically, he is looking at treatment sequencing strategies that maximize clinical response while minimizing patient complications.
Dr. Grotz's clinical and translational interests are in utilizing regional therapeutic approaches to obtain direct surgical access to the tumor and deliver high concentrations of chemotherapy or radiation. This approach allows more directed and targeted treatment while minimizing systemic toxicities.
- Soft tissue sarcoma
- Peritoneal carcinomatosis from colorectal cancer
- Appendiceal cancer
- Peritoneal mesothelioma
- Carcinoid tumors
- Gastric cancers
- Intestinal tumors
Significance to patient care
Dr. Grotz's research has the potential to assist in the development of novel or improved regional therapeutic treatments and ideal treatment sequencing for various types of cancers. In addition, his work may prevent and minimize postoperative complications in patients undergoing complex sarcoma, peritoneal or gastrointestinal cancer surgery.
- Recipient, Thomas H. and Mayme P. Scott Endowed Research Fellowship, MD Anderson Cancer Center, 2016-2017